Found: 56
Select item for more details and to access through your institution.
[<sup>18</sup>F]TFB PET/CT misses intense [<sup>124</sup>I]iodine-avid metastases after redifferentiation therapy in metastatic thyroid cancer.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
A Recommendation for Revised Dose Calibrator Measurement Procedures for <sup>89</sup>Zr and <sup>124</sup>I.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106868
- By:
- Publication type:
- Article
Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm.
- Published in:
- EJNMMI Physics, 2021, v. 8, n. 1, p. 1, doi. 10.1186/s40658-021-00352-z
- By:
- Publication type:
- Article
The Impact of Tumor Cell Proliferation in Radioimmunotherapy.
- Published in:
- Cancer (0008543X), 1994, v. 73, n. S3, p. 974, doi. 10.1002/1097-0142(19940201)73:3+<974::AID-CNCR2820731333>3.0.CO;2-I
- By:
- Publication type:
- Article
Rationales, evidence, and design considerations for fractionated radioimmunotherapy.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. S4, p. 1332, doi. 10.1002/cncr.10304
- By:
- Publication type:
- Article
Theranostic pretargeted radioimmunotherapy of colorectal cancer xenografts in mice using picomolar affinity Y- or Lu-DOTA-Bn binding scFv C825/GPA33 IgG bispecific immunoconjugates.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 5, p. 925, doi. 10.1007/s00259-015-3254-8
- By:
- Publication type:
- Article
PET-based compartmental modeling of I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 11, p. 1700, doi. 10.1007/s00259-015-3061-2
- By:
- Publication type:
- Article
Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 11, p. 2093, doi. 10.1007/s00259-014-2830-7
- By:
- Publication type:
- Article
Phase I pharmacokinetic and biodistribution study with escalating doses of <sup>223</sup>Ra-dichloride in men with castration-resistant metastatic prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 9, p. 1384, doi. 10.1007/s00259-013-2427-6
- By:
- Publication type:
- Article
Detection of hypoxia in microscopic tumors using <sup>131</sup>I-labeled iodo-azomycin galactopyranoside (<sup>131</sup>I-IAZGP) digital autoradiography.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 2, p. 339, doi. 10.1007/s00259-009-1310-y
- By:
- Publication type:
- Article
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 11, p. 1530, doi. 10.1007/s00259-004-1673-z
- By:
- Publication type:
- Article
Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 1, p. 117, doi. 10.1007/s00259-003-1322-y
- By:
- Publication type:
- Article
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 0, doi. 10.1186/s13550-018-0374-8
- By:
- Publication type:
- Article
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.124.267416
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1051, doi. 10.2967/jnumed.124.267416
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 386, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1779, doi. 10.2967/jnumed.123.265763
- By:
- Publication type:
- Article
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 724, doi. 10.2967/jnumed.122.264470
- By:
- Publication type:
- Article
First-in-human imaging with <sup>89</sup>Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229781
- By:
- Publication type:
- Article
<sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
- By:
- Publication type:
- Article
Imaging metastatic castration-resistant prostate cancer patients with <sup>89</sup>Zr-DFO-MSTP2109A anti-STEAP1 antibody.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.222844
- By:
- Publication type:
- Article
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using <sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 11, p. 1517, doi. 10.2967/jnumed.118.222844
- By:
- Publication type:
- Article
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 6, p. 900, doi. 10.2967/jnumed.117.202010
- By:
- Publication type:
- Article
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 161, doi. 10.2967/jnumed.117.194555
- By:
- Publication type:
- Article
Multiparametric Imaging of Tumor Hypoxia and Perfusion with <sup>18</sup>F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1072, doi. 10.2967/jnumed.116.188649
- By:
- Publication type:
- Article
First-in-Human Imaging with <sup>89</sup>Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1858, doi. 10.2967/jnumed.116.176206
- By:
- Publication type:
- Article
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1576, doi. 10.2967/jnumed.115.171371
- By:
- Publication type:
- Article
Cerenkov Luminescence Imaging for Radiation Dose Calculation of a <sup>90</sup>Y-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 5, p. 805, doi. 10.2967/jnumed.114.149054
- By:
- Publication type:
- Article
Image-Guided PO<sub>2</sub> Probe Measurements Correlated with Parametric Images Derived from <sup>18</sup>F-Fluoromisonidazole Small-Animal PET Data in Rats.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 10, p. 1608, doi. 10.2967/jnumed.112.103523
- By:
- Publication type:
- Article
Bone Marrow Dosimetry Using <sup>124</sup>I-PET.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 4, p. 615, doi. 10.2967/jnumed.111.096453
- By:
- Publication type:
- Article
Dosimetric Analysis of <sup>177</sup>Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on <sup>111</sup>In-cG250 Imaging.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 1, p. 82, doi. 10.2967/jnumed.111.094896
- By:
- Publication type:
- Article
<sup>124</sup>I-huA33 Antibody Uptake Is Driven by A33 Antigen Concentration in Tissues from Colorectal Cancer Patients Imaged by Immuno-PET.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 12, p. 1878, doi. 10.2967/jnumed.111.095596
- By:
- Publication type:
- Article
<sup>124</sup>I-huA33 Antibody PET of Colorectal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 8, p. 1173, doi. 10.2967/jnumed.110.086165
- By:
- Publication type:
- Article
Correlation of In Vivo and In Vitro Measures of Carbonic Anhydrase IX Antigen Expression in Renal Masses Using Antibody <sub>124</sub>I-cG250.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 4, p. 535, doi. 10.2967/jnumed.110.083295
- By:
- Publication type:
- Article
<sup>18</sup>F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 3, p. 437, doi. 10.2967/jnumed.110.081372
- By:
- Publication type:
- Article
High <sup>18</sup>F-FDG Uptake in Microscopic Peritoneal Tumors Requires Physiologic Hypoxia.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 4, p. 632, doi. 10.2967/jnumed.109.071233
- By:
- Publication type:
- Article
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Image deconvolution in digital autoradiography: A preliminary study.
- Published in:
- Medical Physics, 2008, v. 35, n. 2, p. 522, doi. 10.1118/1.2828198
- By:
- Publication type:
- Article
The Proportion of Women Who Have a Breast 4 Years after Breast Cancer Surgery: A Population-Based Cohort Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0153704
- By:
- Publication type:
- Article
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 2, p. 783, doi. 10.1007/s00259-021-05543-5
- By:
- Publication type:
- Article
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3047, doi. 10.1007/s00259-020-04832-9
- By:
- Publication type:
- Article
Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 677, doi. 10.1007/s00259-018-4193-y
- By:
- Publication type:
- Article
Monitoring early response to chemoradiotherapy with F-FMISO dynamic PET in head and neck cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 10, p. 1682, doi. 10.1007/s00259-017-3720-6
- By:
- Publication type:
- Article
Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 7, p. 1066, doi. 10.2967/jnumed.107.049502
- By:
- Publication type:
- Article
Phase I Clinical Trial with Fractionated Radioimmunotherapy Using <sup>131</sup>I-Labeled Chimeric G250 in Metastatic Renal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 8, p. 1412
- By:
- Publication type:
- Article
Iodination of Annexin V for Imaging Apoptosis.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 5, p. 671
- By:
- Publication type:
- Article
Relative Therapeutic Efficacy of <sup>125</sup>I- and <sup>131</sup>ILabeled Monoclonal Antibody A33 in a Human Colon Cancer Xenograft.
- Published in:
- Journal of Nuclear Medicine, 2001, v. 42, n. 8, p. 1251
- By:
- Publication type:
- Article